Jefferies Assigns 65–75% Probability of Best-in-Class Efficacy for Definium Therapeutics, Inc.'s (DFTX) DT120 in Phase III
TheFly reported on January 30 that Jefferies initiated coverage of DFTX with a Buy rating and a $30 price target.
Definium Therapeutics Inc. (DFTX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 5,000,000 | $66,950,000 | 0.66% | |
| 2. | Trails Edge Capital Partners Ortav (Tavi) Yehudai | 2,568,110 | $34,386,993 | 8.5% | |
| 3. | Octagon Capital Advisors Ting Jia | 2,230,000 | $29,859,700 | +5% | 3.63% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 2,000,000 | $26,780,000 | -38% | 1.78% |
| 5. | Deep Track Capital David Kroin | 1,676,540 | $22,448,871 | +12% | 0.4% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.17 | 2,500 | $17,925.00 | 19,851 | 2024-12-05 | Filing | |
| $5.98 | 3,500 | $20,930.00 | 17,351 | 2024-08-23 | Filing | |
| $6.12 | 500 | $3,060.00 | 565,543 | 2024-08-20 | Filing | |
| $6.31 | 500 | $3,155.00 | 565,043 | 2024-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.15 | 5,600 | $73,622.64 | 425,025 | 2025-12-26 | Filing | |
| $13.15 | 25,791 | $339,071.70 | 778,477 | 2025-12-26 | Filing | |
| $13.15 | 11,276 | $148,244.44 | 282,576 | 2025-12-26 | Filing | |
| $9.77 | 11,278 | $110,186.06 | 293,852 | 2025-09-25 | Filing | |
| $9.77 | 25,797 | $252,036.69 | 804,268 | 2025-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,273,276 | $110,779,164 | 0% | |
| 2. | 2,591,901 | $34,705,554 | 0% | |
| 3. | 2,411,696 | $32,256,434 | 0.01% | |
| 4. | 2,368,066 | $31,708,404 | 0% | |
| 5. | 2,332,938 | $31,244,186 | 0% |
News See All
7 Most Promising Psychedelic Stocks According to Hedge Funds
The psychedelic industry is poised to have a significant "second wave," transforming from a speculative, counterculture-driven movement into a recognized cornerstone of the US healthcare system.
Hedge Fund Resource Center